Clinical trialNCT07431177RecruitingPhase 2Interventional

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

SponsorNovartis PharmaceuticalsEnrollment210Non-segmental Vitiligo

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

52 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Novartis Investigative Site
Sydney, New South Wales, Australia
Recruiting
Novartis Investigative Site
Waitara, New South Wales, Australia
Recruiting
Novartis Investigative Site
Melbourne, Victoria, Australia
Recruiting

Canada

Novartis Investigative Site
Calgary, Alberta, Canada
Recruiting
Novartis Investigative Site
Winnipeg, Manitoba, Canada
Recruiting
Novartis Investigative Site
Mississauga, Ontario, Canada
Recruiting
Novartis Investigative Site
Newmarket, Ontario, Canada
Recruiting
Novartis Investigative Site
Toronto, Ontario, Canada
Recruiting
Novartis Investigative Site
Québec, Quebec, Canada
Recruiting

China

Novartis Investigative Site
Beijing, China
Recruiting
Novartis Investigative Site
Shanghai, China
Recruiting

France

Novartis Investigative Site
Brest, France
Recruiting
Novartis Investigative Site
Rouen, France
Recruiting
Novartis Investigative Site
Toulouse, France
Recruiting

Germany

Novartis Investigative Site
Munich, Bavaria, Germany
Recruiting
Novartis Investigative Site
Bad Bentheim, Germany
Recruiting
Novartis Investigative Site
Hamburg, Germany
Recruiting
Novartis Investigative Site
Münster, Germany
Recruiting

India

Novartis Investigative Site
Ahmedabad, Gujarat, India
Recruiting
Novartis Investigative Site
Bangalore, Karnataka, India
Recruiting
Novartis Investigative Site
Belagavi, Karnataka, India
Recruiting
Novartis Investigative Site
Mysore, Karnataka, India
Recruiting
Novartis Investigative Site
Nashik, Maharashtra, India
Recruiting

Italy

Novartis Investigative Site
Ancona, AN, Italy
Recruiting
Novartis Investigative Site
Rozzano, MI, Italy
Recruiting

Japan

Novartis Investigative Site
Urayasu, Chiba, Japan
Recruiting
Novartis Investigative Site
Kofu, Yamanashi, Japan
Recruiting
Novartis Investigative Site
Niigata, Japan
Recruiting

Netherlands

Novartis Investigative Site
Amsterdam, North Holland, Netherlands
Recruiting
Novartis Investigative Site
Rotterdam, South Holland, Netherlands
Recruiting

Spain

Novartis Investigative Site
Barcelona, Spain
Recruiting

United States

Cahaba Derm and Skin Hlth Ctr 27
Birmingham, Alabama, United States
Vlada Groysman
Recruiting
First Oc Dermatology
Fountain Valley, California, United States
Vivian Laquer
Recruiting
Medderm Associates
San Diego, California, United States
Michelle Pelle
Recruiting
Clinical Trials Research Institute
Thousand Oaks, California, United States
Navid Ezra
Recruiting
Encore Medical Research
Hollywood, Florida, United States
Jerome Obed
Recruiting
Mayo Clinic Jacksonville
Jacksonville, Florida, United States
Ashley Wentworth
Recruiting
Miami Derm and Laser Institute
Miami, Florida, United States
Jill Waibel
Recruiting
Global Clinical Professionals
St. Petersburg, Florida, United States
Wanda M Boote
Recruiting
Dawes Fretzin Clinical Rea Group
Indianapolis, Indiana, United States
Kenneth Dawes
Recruiting

12 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 9 Mar 2026
Primary completion: 6 Jun 2028
Completion: 28 Jan 2030
Last update posted: 8 Jul 2026
Registered enrollment: 210
Registry id: NCT07431177

Cross-registrations

EU-CTR / CTIS (EudraCT)2025-522301-37-00

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.